Hi Beazley,
Spinogenix increases the density of axospinous glutamatergic synapses. They say it restores cognitive decline in mice.
This study comparatively shows the effects of an mTOR inhibitor ( insert Monepantel) on Glutamatergic synapses.
" Multiple roles of mammalian target of Rapamycin signalling in both Glutamatergic and **Aergic synaptic transmission"
Weston et Al 2012.
We have it covered.
Spinogenix study to compare.
" SPG302 reverses synaptic and cognitive deficits without altering Amyloid or Tau pathology in a transgenic model of Alzheimer's disease. Estrada et al 2021.
Kpax
Hi Beazley,Spinogenix increases the density of axospinous...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $84.92M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.5¢ | $18.91K | 85.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100447 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 17560 | 4 |
View Market Depth
| Last trade - 11.26am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
0.005 ( 8.12 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 21.5¢ | 112571 | ||
| Last updated 11.45am 06/05/2024 ? | |||||
| PAA (ASX) Chart |